Antiproliferative effects of the enantiomers of flurbiprofen

Journal of Clinical Pharmacology

Volumn 36, Issue 6, 1996, Pages 540-545

  McCracken, John D ^a   Wechter, William J ^a   Liu, Youjiang ^a   Chase, Resa L ^b   Kantoci, Darko ^a   Murray Jr , E David ^a   Quiggle, David D ^a   Mineyama, Yoshimitzu ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLURBIPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CELL PROLIFERATION; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ENANTIOMER; FEMALE; INTESTINE CELL; INTESTINE MUCOSA; INTESTINE ULCER; NONHUMAN; ORAL DRUG ADMINISTRATION; PROSTAGLANDIN SYNTHESIS; RAT;

EID: 0030018388     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb05043.x     Document Type: Conference Paper

References (31)

1. Silverberg E, Lubera J: Cancer statistics. CA Cancer J Clin 1987;37:2-19.
2. Anti M, Armelao F, Marra G, Percesepe A, Bartoli G, Palozza P, et al: Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 1994;107:1709-1718.
3. Lipken M, Uehara K, Winawer S, Sanchez A, Bauer G, Phillips R, et al: Seventh-Day Adventist vegetarians have a quiescent proliferative activity in colonic mucosa. Cancer Lett 1985;26:139-144.
4. Anti M, Marra G, Armelao F, Bartoli GM, Ficarelli R, Percesepe A, et al: Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 1992;103:883-891.
5. Lipkin M, Blattner E, Fraumeni JF, Lynch HT, Deschner E, Winawer S: Tritiated thymidine labeling distribution as a marker for the identification of hereditary predisposition to colon cancer. Cancer Res 1983;43:1899-1904.
6. 3H]thymidine labeling patterns in coionic epithelial cells. Cancer Res 1984;44:4201-4207.
7. Welberg JWM, de Vries EGE, Hardonk MJ, Mulder NH, Harms G, Grand J, et al: Proliferation rate of colonic mucosa in normal subjects and patients with colonic neoplasms: a refined immunohistochemical method. J Clin Pathol 1990;43:453-456.
8. Bartram HP, Scheppach W, Schmid H, Hofman A, Dusel G, Richter F, et al: Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, deoxycholate, calcium, ammonia, and pH. Cancer Res 1993;53:3283-3288.
9. Terpstra TO, van Blankenstein M, Dees J, Eilers GAM: Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987;92: 704-708.
10. Suzuki H, Umehara N: Early mucosal changes in dimethylhydrazine-induced colonic carcinogenesis in rats. Jpn J Surg 1986;16: 140-143.
11. Lipkin M, Friedman E, Winawer SJ, Newmark H: Colonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calcium. Cancer Res 1989;49:248-254.
12. Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK: Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 1990;82:555-560.
13. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al: Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-614.
14. Muscat JE, Stellman SD, Wynder EL: Nonsteroidal anti-inflammatory drugs and colorectal cancer. Cancer 1994;74:1847-1854.
15. Olsson NO, Caignard A, Martin MS, Martin F: Effect of indomethacin on the growth of colon cancer cells in syngeneic rats. Int J Immunopharmacol 1984;6:329-334.
16. Skinner SA, Penney AG, O'Brien PE: Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. Arch Surg 1991;126:1094-1096
17. Kudo T, Narisawa T, Abo S: Antitumor activity of indomethacin on methlazoxymethanol-induced large bowel tumors in rats. Gann 1980;71:260-264.
18. Sato M, Narisawa T, Takahasi T, Goto A: Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin. J Cancer Res Clin Oncol 1983;106:21-26.
19. Levi S, Goodland RA, Lee CY, Stamp G, Walport MJ, Wright NA, et al: Inhibitory effect of nonsteroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990;336:840-843.
20. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al: Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:635-639.
21. Waddell WR, Ganser GF, Cerise EJ, Loughry RW: Sulindac for polyposis of the colon. Am J Surg 1989;157:175-179.
22. Rigau J, Pique J, Rubio E, Planas R, Tarrech JM, Bordas JM: Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 1991;115:952-955.
23. Jacoby RF, Marshall DJ, Newton MA, Navarouic K, Tutsch K, Cole CE, et al: Chemoprevention of spontaneous intestinal adenomas in the APC Min mouse model by the nonsteroidal anti-inflammatory drug prioxicam. Cancer Res 1996;56:710-714.
24. Carabaza A, Cabré F, Rotllan E, Gomez M, Gutierrez M, García, et al: Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. J Clin Pharmacol 1996;36:505-512.
25. Brune K, Beck WS, Geisslinger G, Menzel-Soglowek S, Peskar BM, Peskar BA: Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia 1991;47:257-261.
26. Peskar BM, Kluge S, Peskar BA, Soglowek SM, Brune K: Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo. Prostaglandins 1991;42:515-531.
27. Wechter WJ, Bigornia AE, Murray ED Jr, Levine BH, Young JW: Rac-flurbiprofen is more ulcerogenic than its (S)-enantiomer. Chirality 1993;5:492-494.
28. Thoolen B: BrdUrd labeling of S-phase cells in testes and small intestine of mice, using microwave irradiation for immunogold-silvor staining: an immunocytochemical study. J Histochem Cytochem 1990;38:267-273.
29. Nygard G, Anthony A, Khan K, Bounds SVJ, Caldwell J, Dhillon AP, et al: Intestinal site-dependent susceptibility to chronic indomethacin in the rat: a morphologic and biochemical study. Aliment Pharmacol Ther 1995;9:403-410.
30. Shiff SJ, Qiao L, Tsai LL, Rigas B: Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 1995;96:491-503.
31. Jamali F, Berry BW, Tehrani MR, Russell AS: Stereoselective pharmacokinetics of flurbiprofen in humans and rats. J Pharm Sci 1988;77:666-669.